Zobrazeno 1 - 10
of 36
pro vyhledávání: '"A.A. Tieleman"'
Autor:
Johanne M. Groothuismink, Manon Damen, Mascha M.V.A.P. Schijvenaars, Marlies Schimmel-Naber, A.A. Tieleman, Marieke J H Coenen
Publikováno v:
Journal of Neuromuscular Diseases, 8, 715-722
Journal of Neuromuscular Diseases, 8, 4, pp. 715-722
Journal of Neuromuscular Diseases, 8, 4, pp. 715-722
Background: Myotonic dystrophy type 2 (DM2) is caused by a CCTG repeat expansion in intron 1 of the CCHC-Type Zinc Finger Nucleic Acid Binding Protein (CNBP) gene. Previous studies indicated that this repeat expansion originates from separate founder
Autor:
Fran H.P. Smulders, A.A. Tieleman, Joost Raaphorst, Joost Berends, Baziel G.M. van Engelen, Nicol C. Voermans, Corinne G.C. Horlings
Publikováno v:
Neuromuscular Disorders, 29, 758-765
Neuromuscular disorders, 29(10). Elsevier Limited
Neuromuscular Disorders, 29, 10, pp. 758-765
Neuromuscular disorders, 29(10). Elsevier Limited
Neuromuscular Disorders, 29, 10, pp. 758-765
We aimed to examine the incidence as well as the circumstances and the consequences of falling in adult patients with myotonic dystrophy type 1 and 2 (DM1/DM2). We performed a prospective cohort study in 209 subjects, of which 102 had DM1, 42 had DM2
Autor:
Hans Timmerman, A.A. Tieleman, Oliver H.G. Wilder-Smith, Judith van Vliet, Aad Verrips, Baziel G.M. van Engelen, Robert van Dongen
Publikováno v:
van Vliet, J, Tieleman, A A, Verrips, A, Timmerman, H, van Dongen, R T M, van Engelen, B G M & Wilder-Smith, O H G 2018, ' Qualitative and Quantitative Aspects of Pain in Patients With Myotonic Dystrophy Type 2 ', Journal of Pain, vol. 19, no. 8, pp. 920-930 . https://doi.org/10.1016/j.jpain.2018.03.006
Journal of Pain, 19, 920-930
Journal of Pain, 19, 8, pp. 920-930
Journal of Pain, 19, 920-930
Journal of Pain, 19, 8, pp. 920-930
Pain is a common but often ignored symptom in patients with myotonic dystrophy type 2 (DM2). In this explorative study, we assessed qualitative and quantitative aspects of pain in DM2 using 4 questionnaires and quantitative sensory testing. A disease
Publikováno v:
Neuromuscular Disorders, 28, 10, pp. 878-880
Neuromuscular Disorders, 28, 878-880
Neuromuscular Disorders, 28, 878-880
We report a patient with progressive proximal muscle weakness in her legs, early-onset cataract and perceptive hearing loss, who was recently diagnosed with myotonic dystrophy type 2 (DM2). She also had two autoimmune disorders in her history, namely
Autor:
William Howlett, H.A. van Duyvenvoorde, A.A. Tieleman, O.J. Igogo, Marieke C. J. Dekker, Ben C.J. Hamel
Publikováno v:
Neuromuscular Disorders, 29, 317-320
Neuromuscular Disorders, 29, 4, pp. 317-320
Neuromuscular Disorders, 29(4), 317-320. PERGAMON-ELSEVIER SCIENCE LTD
Neuromuscular Disorders, 29, 4, pp. 317-320
Neuromuscular Disorders, 29(4), 317-320. PERGAMON-ELSEVIER SCIENCE LTD
In African neurological practice, muscle disorders are either underdiagnosed or underrepresented. This may in part be due to the large burden of other more common neurological disorders. In this report we describe the first Tanzanian patient with gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0752a7384cf77838f3b6b66d836efc0
http://hdl.handle.net/2066/207145
http://hdl.handle.net/2066/207145
Autor:
G. Bassez, Wim I. M. Verhagen, A.A. Tieleman, Judith van Vliet, George Lamas, Joost A.M. Engel, Elisabeth Mamelle, Baziel G.M. van Engelen, Tanya Stojkovic, Anthony Béhin, Bruno Eymard, Laurent Servais, Jan Meulstee
Publikováno v:
Neurology
Neurology, 2018, 90 (7), pp.e615-e622. ⟨10.1212/WNL.0000000000004963⟩
Neurology, 90, 7, pp. E615-E622
Neurology, 90, E615-E622
Neurology, 2018, 90 (7), pp.e615-e622. ⟨10.1212/WNL.0000000000004963⟩
Neurology, 90, 7, pp. E615-E622
Neurology, 90, E615-E622
ObjectiveTo systematically assess auditory characteristics of a large cohort of patients with genetically confirmed myotonic dystrophy type 2 (DM2).MethodsPatients with DM2 were included prospectively in an international cross-sectional study. A stru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee90eb21eafbfb1f4322cb5d336091b3
https://hal.science/hal-03875067
https://hal.science/hal-03875067
Autor:
A.A. den Broeder, A.A. Tieleman, H. Cats, Hans Scheffer, Aad Verrips, J.A. van der Vliet, B.G.M. van Engelen
Publikováno v:
Neuromuscular Disorders, 26, 370-3
Neuromuscular Disorders, 26, 6, pp. 370-3
Neuromuscular Disorders, 26, 6, pp. 370-3
Item does not contain fulltext Myotonic dystrophy type 2 (DM2) is a rare, autosomal dominant, multisystem disorder with proximal weakness, myotonia, pain and cataract as important symptoms. Given the assumed underreporting of DM2 in the Netherlands c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66bb2332328e49d80d2297d9ed47f06c
http://hdl.handle.net/2066/167988
http://hdl.handle.net/2066/167988
Autor:
Baziel G.M. van Engelen, Hans Knoop, Anne-Els van de Logt, Gijs Bleijenberg, Sebastiaan Overeem, A.A. Tieleman
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry, 81, 9, pp. 963-7
Journal of Neurology, Neurosurgery, and Psychiatry, 81, 963-7
Journal of Neurology, Neurosurgery, and Psychiatry, 81, 963-7
Contains fulltext : 89720.pdf (Publisher’s version ) (Closed access) BACKGROUND: In myotonic dystrophy type 1 (DM1), sleep disorders are common, with excessive daytime sleepiness (EDS) as a predominant feature. In myotonic dystrophy type 2 (DM2), t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anneke J. van der Kooi, A.A. Tieleman, Judith van Vliet, George F. Borm, Baziel G.M. van Engelen, Jan B.M.J. Jansen
Publikováno v:
Neuromuscular disorders, 18(8), 646-649. Elsevier Limited
Neuromuscular Disorders, 18, 8, pp. 646-9
Neuromuscular Disorders, 18, 646-9
Neuromuscular Disorders, 18, 8, pp. 646-9
Neuromuscular Disorders, 18, 646-9
Contains fulltext : 70215.pdf (Publisher’s version ) (Closed access) The phenotype of DM2 shows similarities as well as differences to that of Myotonic Dystrophy type 1 (DM1). Gastrointestinal dysfunction is common in DM1 and 25% of the patients co